Fresh Recalls

FDAClass II · Medical device · Recall Z-2770-2026 · Recalled July 29, 2026

Penumbra System RED 68 Reperfusion Catheter REF recall — Penumbra, Inc.

Agency report date: July 29, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Penumbra System RED 68 Reperfusion Catheter REF
Company / brand
Penumbra
Lot / serial / date codes
UDI: 00815948024113/Lots: H00008699, H00008701, H00008702, H00008703, and C00020038
Distribution
Worldwide - US Nationwide distribution including in the states and territories of AK, AL, AE, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KY, MA, MD, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, Puerto Rico and the countries of Brazil, Canada, Colombia, Ecuador, Indonesia, Israel, Lebanon, Mexico, Mongolia, Philippines, Saudi Arabia, Thailand, and United Arab Emirates.
Agency product description and boundaries

Penumbra System RED 68 Reperfusion Catheter REF: RED68KIT

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Due to manufacturing issues, reperfusion catheters may fractures

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Penumbra System RED 68 Reperfusion Catheter REF

3. Open the official notice or contact

Official recall ID
Z-2770-2026
Brand
Penumbra
Classification
Class II
Units affected
N/A
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Livermore, CA, United States
Firm address
6262 Patterson Pass Rd Ste A, N/A, 94550-9576

Identifying details (verbatim from the notice)

Product codes / lots
UDI: 00815948024113/Lots: H00008699, H00008701, H00008702, H00008703, and C00020038
Distribution
Worldwide - US Nationwide distribution including in the states and territories of AK, AL, AE, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KY, MA, MD, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, Puerto Rico and the countries of Brazil, Canada, Colombia, Ecuador, Indonesia, Israel, Lebanon, Mexico, Mongolia, Philippines, Saudi Arabia, Thailand, and United Arab Emirates.
Firm notified the public via
Letter
FDA event ID
99148
Recall initiated
June 3, 2026
FDA classified
July 21, 2026
FDA report date
July 29, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page